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Abstract 
 
Tubulocystic renal cell carcinoma of the kidney is a rare entity with less than one hundred 
cases reported so far. It was previously considered to have some similarities to various other 
renal cancers although this tumor has distinct macroscopic, microscopic and immuno-
histochemical features. It is now a well-established entity in renal neoplastic pathology and 
has been recognized as a distinct entity in the 2012 Vancouver classification of renal 
tumors. This review aims to give an overview of tubulocystic renal cell carcinoma after 
extensive literature search using PubMed and CrossRef.  Copyright: The Authors. 
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Introduction  
Kidney cancer is among the ten most 
common causes of cancer related deaths in 
adults (1). The National Institute of Health 
estimates around 63,920 new cases of 
kidney cancer and 13,860 deaths from this 
disease in 2014 (2). The common renal cell 
carcinomas of clear cell, papillary and 
chromophobe types account for 85–90% of 
the renal tubular malignancies and the 
remaining 10–15% includes a variety of 
uncommon sporadic and familial 
carcinomas, some of which have been 
recently described, along with a group of 
unclassified carcinomas. One of these 
tumors is extremely rare and is known as 
tubulocystic renal cell carcinoma.  
Tubulocystic renal cell carcinoma of the 
kidney is a recently established entity in 
renal neoplastic pathology. It was first 
described by Pierre Masson in 1956 who 
described cystic neoplasm of the kidney 
with hobnail cells in the central region of 
the kidney (3). It was thought to be in 
collecting duct and was hence called 
carcinoma of Bellini (Collecting) duct. It 
was later found to be low grade and differ 
significantly in behavior when compared to 
classic type which was far more aggressive. 
Accordingly, it was termed as “low-grade 
collecting duct carcinoma”. In 1997 
MacLennan et al. hypothesized that this 
tumor represented the low grade of the 
spectrum of collecting duct carcinoma 
(CDC), as it shares similar characteristics 
with the latter tumor (4). A recent study by 
Osunkoya et al. has shown that 
tubulocystic renal cell carcinoma is distinct 
from CDC at the molecular level (5).  It 
received its current name in 2004 in a 
series of 31 cases presented in an abstract 
at the United States and Canadian 
Academy of Pathology meeting by Amin et 
al (6). Tubulocystic renal cell carcinoma 
was not included in the WHO 2004 
classification. However, it was recognized 
as a distinct entity in 2010 by the 
American Joint Committee on Cancer. In 
2012, it was included in the Vancouver 
classification of renal cancer (7).  
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Search Criteria 
We performed English literature search 
using Pubmed and Crossref on 10th August 
2014, which yielded more than 80 results 
of published material on Pubmed. The 
search terms used were “tubulocystic renal 
cell cancer” and “tubulocystic carcinoma 
pathology / metastasis / 
immunohistochemistry” and “uncommon 
cystic renal tumors”. We have critically 
analyzed and included most of the 
important case series, reports and previous 
reviews from 1970- August 2014 in our 
review. Cases appear to be focusing on 
tumor histology and differentiation with 
other similar subtypes of renal tumors. 
There has been a surge in the reports and 
reviews in the past 7 – 8 years indicating a 
recent interest among researchers in the 
study and management of this tumor. Here 
in, we review the literature about 
tubulocystic renal cell carcinoma.  
Clinical features 
Clinically, tubulocystic renal cell carcinoma 
is a tumor of adults mostly presenting in 
the fifth and sixth decade with a wide age 
range, 29–94 years. It shows a strong male 
predominance with a male/ female ratio of 
7:1. Reported tumors are more often left 
sided (8). Tubulocystic renal cell carcinoma 
is usually solitary; however, based on the 
literature, multifocality appears to be a 
common phenomenon in up to 23% of 
cases (8-9). They are less aggressive than 
other renal cell carcinomas. Patients are 
often asymptomatic, although they may 
present with abdominal pain, distension 
and hematuria. Most present with small 
tumors (pT1), however, occasional pT2 and 
pT3 lesions have been reported. They rarely 
progress, recur, or metastasize (10). In the 
vast majority of reports, this has been an 
incidental finding on autopsy, nephrectomy 
for a separate disease process, or imaging 
(6). Clinical characteristics reported in 
different studies have been explained in 
Table 1.  
Only a few cases so far have been reported 
of metastases to lymph node, bone, pleura, 
and liver (11). Its relationship to collecting 
duct carcinoma is controversial, and recent 
studies have linked it with papillary RCC. 
Only one case of tubulocystic carcinoma 
with sarcomatoid features has been 
reported where the patient developed 
multiple peritoneal metastases and died 14 
months after diagnosis (12).  
Gross Description 
Grossly, it is usually solitary, although 
multifocal examples may be seen. The 
tumors show a variable size, ranging from 
0.3 to 17 cm, with a mean of 4 cm. The 
tumors are well circumscribed and usually 
un-encapsulated involving mainly the renal 
cortex. The cut surface of tumor is white or 
gray often compared to “bubble wrap”. It 
reveals small multilocular cystic spaces 
reminiscent of the appearance of a 
‘‘sponge’’ or ‘‘Swiss cheese’’ (9).  
Microscopic Description  
Microscopically, tubulocystic renal cell 
carcinoma is composed of tightly packed 
tubules and cysts measuring up to a few 
millimeters in diameter, separated by bland 
fibrous stroma. The lining cells are 
cuboidal to columnar and may have an 
attenuated appearance. Hobnail cells are 
commonly seen (Figure 1A & B). The cells 
have abundant eosinophilic or amphophilic 
cytoplasm and the nuclei are large and 
have prominent nucleoli. The nuclear grade 
generally corresponds to Fuhrman grade 3, 
but grade 2 or even grade 1 may be seen 
(8,13). Nuclear chromatin is evenly 
dispersed. A solid sheet pattern is absent 
(9). Occasional cells with low grade nuclear 
changes may be seen but they rarely 
predominate. Rarely minor areas with clear 
cell or papillary features are noted (17). 
Foam cells, calcospherites and hemosiderin 
encrustation are not found, unless there is 
an accompanying papillary renal cell 
carcinoma (4). Electron microscopy reveals 
abundant microvilli in most cells with a 
brush border appearance resembling 
proximal convoluted tubules. Admixed cells 
with short, sparse microvilli and complex 
cytoplasmic interdigitation, reminiscent of 
intercalated cells of collecting duct are also 
seen (8).  
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   Table 1: Clinical characteristics of TCRC 
Number 
of cases 
Age 
range 
(years) 
Sex 
Size 
range 
(cm) 
Location 
(kidney) 
Nature of 
tumor 
(recurrenc
e) 
Metastasis 
 
Ref 
13 36-94 
10(M) : 
3(F) 
 
0.5 – 
8.5 
R=6; L=7 
 
Nil 
1 case: local 
lymph nodes 
 
9 
20 36-87 
16(M) : 
4(F) 
0.2 – 
6.1 
R>L 
 
Only 1 case 
recurred 
1 case: local 
1 case: distant 
17 
11 30-80 11 (M) 1.7 – 7 
Data not 
available 
Nil Nil 13 
31 34-74 
27(M): 
4(F) 
0.7-17 L>R Nil 2 cases: local 6 
6 29-83 
3(M): 
3(F) 
 
1.9-4.0 R=5; L=1 Nil 
1 case: local 
lymph node 
18 
5 29-70 
4 (M) 
One is 
missing 
5.1 – 
6.7 
R>L; 
3 
1 case: 
recurrence; 
1 death 
2 case: distant 
metastasis 
19 
1 33 M 5x2.7 L 
Recurrence 
in 
peritoneum 
Distant 
metastasis  
12 
1 43 M - R - - 15 
1 28 F 12 R Solitary 
Local 
metastasis 
20 
4 30-74 3(M): 1(F) 
1.9 – 
14.5 
L>R 
No 
recurrence 
reported 
No metastasis 
reported 
21 
3 50-70 3(M) 
3.8-
14.0 
 
No 
recurrence 
reported 
1 vascular 
invasion 
2 perinephric 
adipose tissue 
22 
1 70 M 
15.1x1
1.6x9. 
L 
No 
recurrence 
Bone 
Metastasis 
23 
1 35 F 
0 
10x12 
L 
No 
recurrence 
reported 
No metastasis 
reported 
24 
    Summary    
~98 29-94 M>F 0.2 – 17 L>R 
Less 
chances of 
recurrence 
Local and 
distant 
metastasis 
 
 
Molecular characteristics 
Immunohistochemistry demonstrates a 
poor relationship between tubulocystic 
renal cell carcinoma and collecting duct 
tumors. These tumors show expression of 
proteins of proximal convoluted tubules 
(CD10 and P504S), distal tubules (CK19) 
and intercalated collecting duct cells 
(parvalbumin). They also show vimentin, 
p53 and alpha methylacyl CoA racemase 
(AMACR) over-expression in contrast to 
CDC. High molecular weight cytokeratin 
(34BE12) is nearly always negative (5).  
Gene expression microarray analysis by 
Yang et al. (9) demonstrated a unique 
molecular signature of tubulocystic renal 
cell carcinoma in comparison to other renal 
tumors and normal renal tissue. Clustering 
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Figure 1. Microscopic appearance of tubulocystic renal cell carcinoma. A, hematoxylin and eosin (H & 
E) staining shows tubulopapillary pattern with cystic spaces lined with cells having hobnail 
appearance (x200); B, H & E shows tubular and tubulopapillary structures in a hyalinized and fibrous 
stroma (x200). 
 
analysis of that data revealed tubulocystic 
renal cell carcinoma to be closely related to 
papillary RCC. Both types 1 and 2 
dimensional clustering placed tubulocystic 
carcinoma between low and high grade 
papillary RCC. The most common 
karyotypic changes in papillary RCC are 
trisomy 7 and 17 with loss of Y 
chromosome. Yang et al (9) also reported 
that tubulocystic renal cell carcinoma 
showed gain of chromosome 17, but not 
chromosome 7. Thus, although 
tubulocystic renal cell carcinoma has been 
reported in association with multiple other 
renal cell tumor subtypes, it appears that 
there is a slight predominance for 
synchronous tubulocystic carcinoma and 
papillary tumors. These reports of 
coexistence thus raise an interesting 
question about presence of common 
predisposing factors for these histologically 
different tumors. 
Diagnostic investigations play a very 
pertinent role as several differential 
diagnoses are to be considered. This is 
especially important since tubulocystic 
renal cell carcinoma may be associated 
with malignant behavior, that is, a high 
vigilance for potential metastatic disease. 
As the tumors have cystic elements, the 
radiological differential diagnostic spectrum 
is broad, including lesions that may be 
classified as a Bosniak type III or IV. 
Differential diagnoses 
The clinical and pathological aspects of 
tubulocystic carcinoma are still not well 
studied. A combination of histology, 
electron microscopy and 
immunohistochemistry are required for 
proper diagnosis. The main differential 
diagnosis of tubulocystic carcinoma 
includes collecting duct carcinoma and 
other cystic tumors including cystic 
nephroma, multilocular cystic RCC, and 
oncocytoma (14). Cystic nephroma is 
characterized by larger cysts with 
hyalinized or fibrotic stroma. The cysts are 
lined by flat to attenuated cells with 
occasional hobnailing. However, unlike 
tubulocystic renal cell carcinoma, the 
nuclei are typically benign with absent or 
inconspicuous nucleoli. Cystic nephroma 
has a characteristic ovarian-like stroma 
between the cyst, which is often positive for 
estrogen and progesterone receptors. In 
addition, cystic nephroma occurs almost 
always in females, whereas tubulocystic 
renal cell carcinoma is more common in 
males. Multilocular cystic renal cell 
carcinoma is characterized by variably 
sized cystic spaces lined by flattened to 
cuboidal clear cells separated by fibrous 
stroma containing small groups of clear 
cells of low Fuhrman nuclear grade. 
Oncocytoma may have in a minority of 
cases prominent dilated tubules, which can 
resemble tubulocystic renal cell carcinoma, 
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as they both have abundant eosinophilic 
cytoplasm and can have cells with 
prominent nucleoli. However, the nuclei in 
oncocytoma are round or, if irregular, have 
degenerative atypia; whereas in 
tubulocystic renal cell carcinoma, the 
nuclei are irregular without degenerative 
features. Collecting duct carcinoma and 
renal medullary carcinoma occur in the 
renal medulla; and demonstrate a poorly 
differentiated adenocarcinoma, 
inflammatory infiltration, frequent 
perirenal fat invasion, lymphovascular 
invasion, intraluminal mucin and high 
nuclear grade (5). 
Management and outcome 
Radical nephrectomy is generally 
recommended, but partial nephrectomy 
may be performed for small tumors located 
in the superficial renal cortex. Sunitinib, a 
tyrosine kinase inhibitor, may exhibit a 
partial response or temporary effect for this 
tumor (15). Tubulocystic renal cell 
carcinoma of the kidney with sarcomatoid 
change has responded poorly to sorafenib 
(12). The antiangiogenic targeted 
therapeutic protocols such as VHL/HIF, 
RTK/MAPK and PI3K/Akt/mTOR seem to 
have no rationale of general 
recommendation (16). In the three largest 
series totaling 34 cases with follow-up, only 
3 developed metastases to lymph node, 
bone and liver.  In contrast, in a series of 3 
cases by Al Hussain et al. (22), one was 
with vascular invasion and two were with 
invasion to perinephric adipose tissue. This 
study reported 2 cases with poorly 
differentiated areas consisting of collecting 
duct–like carcinoma areas, and one with 
focal high-grade features with marked 
nuclear atypia and prominent nucleoli. 
Apart from this, there is only one similar 
description in the literature. Bhullar et al. 
recently reported 1 case of tubulocystic 
renal cell carcinoma with tubulopapillary 
pattern and focal sarcomatoid areas that 
developed multiple peritoneal metastases, 
and the patient died 14 months after 
diagnosis (12). Limited work has been 
reported in this regard and it raises 
concern that tubulocystic renal cell 
carcinoma with poorly differentiated areas 
increases the risk of aggressive behavior 
above that of usual tubulocystic renal cell 
carcinoma. 
Conclusion 
Tubulocystic renal cell carcinoma is a 
distinct group of renal carcinoma with 
specific macroscopic, microscopic and 
immunohistochemical findings. It appears 
to have a close relation to papillary 
carcinoma. Tubulocystic renal cell 
carcinoma should be considered in 
differential diagnosis of cystic kidney 
lesions, along with cystic nephroma, 
multilocular cystic renal cell carcinoma, 
oncocytoma with prominent tubules and 
cysts, and mixed epithelial and stromal 
tumor of the kidney. However, it is 
distinctly different from these entities with 
regard to radiological findings, including 
growth pattern, the presence of cystic 
components and also in their biological 
aggressiveness. Tubulocystic renal cell 
carcinoma with poorly differentiated areas 
increases the risk of aggressive behavior 
above that of usual tubulocystic renal cell 
carcinoma. To date, no established 
guidelines have been given for the 
management of this tumor. The 
examination of more cases is required to 
understand its biology and ascertain true 
prognosis and appropriate treatment. 
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